[1]
Harzalina Zilfi Amly et al. 2025. Efficacy and Safety Comparison between Empagliflozin and Linagliptin among Type 2 Diabetes Mellitus Patients : A Systematic Review and Meta-Analysis. Jurnal Ilmu Multidisiplin. 4, 1 (May 2025), 420–427. DOI:https://doi.org/10.38035/jim.v4i1.865.